Search Results - "Baarsma, M. E."

Diagnostic Performance of the Novel BioPlex Lyme Serological Assays in European Patients with Lyme Disease by Baarsma, M E (Ewoud), Ursinus, Jeanine, Zaaijer, Hans L, Kuiper, Herman, Hovius, Joppe W

“…Serodiagnosis of Lyme borreliosis (LB) comes with several drawbacks, among which is limited sensitivity in early disease. This study assesses the sensitivity…”
Get full text

Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnaires by van de Schoor, F. R., Baarsma, M. E., Gauw, S. A., Ursinus, J., Vrijmoeth, H. D., ter Hofstede, H. J. M., Tulen, A. D., Harms, M. G., Wong, A., van den Wijngaard, C. C., Joosten, L. A. B., Hovius, J. W., Kullberg, B. J.

“…Objectives To describe the course of symptoms reported by patients with symptoms attributed to Lyme borreliosis (LB) without being subsequently diagnosed with…”
Get full text

Validation of cellular tests for Lyme borreliosis (VICTORY) study by van de Schoor, F R, Baarsma, M E, Gauw, S A, Joosten, L A B, Kullberg, B J, van den Wijngaard, C C, Hovius, J W

“…Lyme borreliosis (LB) is a tick-borne disease caused by spirochetes belonging to the Borrelia burgdorferi sensu lato species. Due to a variety of clinical…”
Get full text

Opinion: Methodological Shortcomings in the Study on a Prophage-based PCR Test for Lyme Borreliosis by van de Schoor, Freek R, Baarsma, M E, Leeflang, Mariska M G, Fingerle, Volker, Margos, Gabriele, Hovius, Joppe W, van Dam, Alje P

Get full text

Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease by Baarsma, ME, Schellekens, JFP, Meijer, BC, Brandenburg, AH, Souilljee, T., Hofhuis, A, Hovius, JW, van Dam, AP

“…Modified two-tier testing (MTTT) for Lyme borreliosis (i.e. confirmation with an EIA instead of an immunoblot) has been shown to have improved sensitivity…”
Get full text

Knowing the entire story - a focus group study on patient experiences with chronic Lyme-associated symptoms (chronic Lyme disease) by Baarsma, M E, Claassen, S A, van der Horst, H E, Hovius, J W, Sanders, J M

“…Healthcare providers frequently struggle to provide effective care to patients with chronic Lyme-associated symptoms (chronic Lyme disease, CLD), potentially…”
Get full text

Persistent Symptoms After Lyme Disease: Clinical Characteristics, Predictors, and Classification by Baarsma, M E, Hovius, Joppe W

“…Abstract Persistent symptoms after an infection have been described for a number of infectious diseases, including Lyme disease. Studies have confirmed a…”
Get full text

Digital disparities among healthcare workers in typing speed between generations, genders, and medical specialties: cross sectional study by Schuurman, Alex R, Baarsma, M E, Wiersinga, W Joost, Hovius, Joppe W

“…To investigate the typing skills of healthcare professionals. Cross sectional study. Two large tertiary medical centres in Amsterdam, the Netherlands. 2690…”
Get more information

The initial QuantiFERON-Lyme prototype is unsuitable for European patients by Baarsma, M E, van de Schoor, F R, van den Wijngaard, C C, Joosten, L A B, Kullberg, B J, Hovius, J W

Get full text

Diagnostic performance of the ZEUS Borrelia VlsE1/pepC10 assay in European LB patients: a case–control study by Baarsma, M. E., Vrijlandt, A., Ursinus, J., Zaaijer, H. L., Jurriaans, S., van Dam, A. P., Hovius, J. W.

“…This retrospective case-control study assesses the sensitivity, specificity, and area under the curve of the ZEUS Borrelia VlsE1/pepC10 assay in comparison…”
Get full text

Diagnostic parameters of cellular tests for Lyme borreliosis in Europe (VICTORY study): a case-control study by Baarsma, M E, van de Schoor, Freek R, Gauw, Stefanie A, Vrijmoeth, Hedwig D, Ursinus, Jeanine, Goudriaan, Nienke, Popa, Calin D, ter Hofstede, Hadewych JM, Leeflang, Mariska MG, Kremer, Kristin, van den Wijngaard, Cees C, Kullberg, Bart-Jan, Joosten, Leo AB, Hovius, Joppe W

“…Cellular tests for Lyme borreliosis might be able to overcome major shortcomings of serological testing, such as its low sensitivity in early stages of…”
Get full text

Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production by Kerstholt, Mariska, van de Schoor, Freek R, Oosting, Marije, Moorlag, Simone J C F M, Li, Yang, Jaeger, Martin, van der Heijden, Wouter A, Tunjungputri, Rahajeng N, Dos Santos, Jéssica C, Kischkel, Brenda, Vrijmoeth, Hedwig D, Baarsma, M E, Kullberg, Bart-Jan, Lupse, Mihaela, Hovius, Joppe W, van den Wijngaard, Cees C, Netea, Mihai G, de Mast, Quirijn, Joosten, Leo A B

“…Previous studies have shown that monocytes can be 'trained' or tolerized by certain stimuli to respond stronger or weaker to a secondary stimulation. Rewiring…”
Get full text

Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study by Vrijmoeth, Hedwig D, Ursinus, Jeanine, Harms, Margriet G, Tulen, Anna D, Baarsma, M E, van de Schoor, Freek R, Gauw, Stefanie A, Zomer, Tizza P, Vermeeren, Yolande M, Ferreira, José A, Sprong, Hein, Kremer, Kristin, Knoop, Hans, Joosten, Leo A B, Kullberg, Bart Jan, Hovius, Joppe W, van den Wijngaard, Cees C

“…Patients treated for Lyme borreliosis (LB) frequently report persistent symptoms. Little is known about risk factors and etiology. In a prospective…”
Get full text

Second-degree atrioventricular block caused by Lyme disease by van der Zande, J M J, Baarsma, M E, Grundeken, M J, Verhaar, N, Kok, W E M, Hovius, J W

“…Tick-borne diseases, including Lyme disease, are becoming increasingly common in Europe. Lyme disease has a wide variety of clinical manifestations, as a…”
Get more information